Clinical Trials Browser

Phase 2 × Hot Flashes × Breast × Clear all

NCT01530373 2026-03-05

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

Phase 2 Recruiting

Breast Neoplasms, Hot Flashes

NCT04821141 2025-10-29

Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

Phase 2 Active not recruiting

Breast Neoplasms, Hot Flashes, Risk Reduction Behavior

NCT02513329 2023-06-05

Stellate Ganglion Block (SGB) For Women for Breast Cancer

Phase 2 Completed

37 enrolled 18 charts

Breast Neoplasms, Hot Flashes

NCT00110136 2021-09-29

St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer

Phase 2 Terminated

9 enrolled 10 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Hot Flashes

NCT01439945 2017-04-04

Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer

Phase 2 Completed

289 enrolled 13 charts

Breast Neoplasms, Hot Flashes

NCT00031720 2016-07-13

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

Phase 2 Completed

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Hot Flashes

NCT01008904 2016-06-21

Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer

Phase 2 Completed

31 enrolled 8 charts

Breast Neoplasms, Hot Flashes

NCT00198250 2008-11-14

Venlafaxine for Hot Flashes After Breast Cancer

Phase 2 Completed

Breast Neoplasms, Hot Flashes